- The shares of Cassava Sciences (SAVA) recently received a $44 price target. These are the details.
The shares of Cassava Sciences (SAVA) recently received a $44 price target.
Price target: $44
Rating: Downgraded from “Buy” to “Neutral”
Analyst firm: B. Riley
B. Riley analysts adjusted the rating while citing that recent non-material pipeline and corporate developments as discussed in the third-quarter earnings announcement do not necessarily explain why shares have rallied about 175% off their year-to-date lows seen in late July. And while the analysts are encouraged by the steady pace of expanding enrollment in Phase 3 Alzheimer’s trials, they believe that the company was adversely impacted by limited relevant data disclosures from its ongoing Phase 2 open-label studies.